Boston Scientific Corporation (BSX) vs McKesson Corporation (MCK)
BSX leads on 8 of 14 compared metrics.
A side-by-side comparison of Boston Scientific Corporation and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BSX
Boston Scientific Corporation
$44.95Healthcare
MCK
McKesson Corporation
$750.63Healthcare
Total return — BSX vs MCK
growth of $100 · last 30yBSX +358.8%MCK +3003.1%MCK compounded faster
Log scale — wide-divergence pair
BSX MCK
BSX vs MCK: by the numbers
- •MCK is the larger company ($87.88B vs $67.35B market cap).
- •BSX trades at the lower earnings multiple (18.89 vs 19.51 P/E).
- •BSX converts more revenue to profit (17.24% vs 1.18% net margin).
- •BSX grew revenue faster over the past five years (15.29% vs 11.11% CAGR).
- •MCK pays a dividend (0.44% yield) while BSX does not currently pay one.
Which is better, BSX or MCK?
Metric tally: BSX 8 · MCK 6It depends on what you're optimizing for:
ValueBSX(lower P/E)
GrowthBSX(faster 5Y revenue CAGR)
QualityMCK(higher ROIC)
Metrics side by side
Valuation
| Metric | BSX | MCK |
|---|---|---|
| P/E ratio | 18.89● | 19.51 |
| Forward P/E | 12.07● | 14.90 |
| P/S ratio | 3.26 | 0.23● |
| P/B ratio | 2.60 | — |
| PEG ratio | 0.88 | 0.46● |
| EV / EBITDA | 13.55 | 13.79 |
| FCF yield | 5.12% | 6.44%● |
Profitability
| Metric | BSX | MCK |
|---|---|---|
| Gross margin | 70.41%● | 3.61% |
| Operating margin | 20.12%● | 1.58% |
| Net margin | 17.24%● | 1.18% |
| ROE | 13.74%● | -219.24% |
| ROIC | 8.78% | 31.48%● |
Dividends
| Metric | BSX | MCK |
|---|---|---|
| Dividend yield | — | 0.44% |
| Payout ratio | — | 8.51% |
Growth (annualized)
| Metric | BSX | MCK |
|---|---|---|
| Revenue CAGR (5Y) | 15.29%● | 11.11% |
| EPS CAGR (5Y) | -8.67% | 40.71%● |
| FCF CAGR (5Y) | 19.89%● | 8.76% |
| Total return CAGR (5Y) | 1.04% | 33.07%● |
Frequently asked
- Which is better, BSX or MCK?
- It depends on your goal. value: BSX (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: MCK (higher ROIC). Across all compared metrics, BSX leads 8 to 6.
- Is BSX or MCK cheaper?
- On trailing earnings, BSX is cheaper: BSX trades at a 18.89 P/E and MCK at 19.51.
- Which has grown faster, BSX or MCK?
- Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus MCK at 11.11%.
- Does BSX or MCK pay a bigger dividend?
- MCK pays a dividend (0.44% yield) while BSX does not currently pay one.
- Is BSX or MCK more profitable?
- BSX runs the higher net margin — BSX at 17.24% versus MCK at 1.18%.
- Which has been the better investment, BSX or MCK?
- Over the past 10-year, MCK delivered the higher annualized total return — BSX at 7.25% versus MCK at 16.38%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioMcKesson P/E ratioBoston Scientific dividend yieldMcKesson dividend yieldBoston Scientific ROEMcKesson ROEBoston Scientific operating marginMcKesson operating marginBoston Scientific revenue growthMcKesson revenue growthBoston Scientific free cash flowMcKesson free cash flow
Boston Scientific & McKesson appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.